ArticleCureus2025
Unequal Burden: Racial Differences in Mortality, Complications, and Resource Utilization in Immune Thrombocytopenia Hospitalizations.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction Immune thrombocytopenia (ITP) is characterized by the autoimmune destruction of platelets and is a diagnosis of exclusion. It can range from asymptomatic to spontaneous bleeding. Race significantly affects healthcare utilization and clinical outcomes of ITP hospitalizations. We aimed to determine the number of ITP hospitalizations in 2022 and investigate how race influences admission, clinical outcomes, and healthcare utilization. Methods We retrospectively analyzed ITP-related hospitalizations using the 2022 National Inpatient Sample (NIS). Patients were categorized by race into six groups: White, African American, Hispanic, Asian or Pacific Islander, Native American, and Other. Data analysis was conducted using STATA/BE version 18.5. Univariate and multivariable logistic regression models were used to assess the associations between race, clinical outcomes, and healthcare utilization metrics. Results In 2022, 315,277 hospitalizations were recorded for ITP. Of these, 56.35% were male and 43.65% were female. 64.5% of patients identified themselves as White, 12.5% as Hispanic, 13.3% as African-American, 3.5% as Asian or Pacific Islander, 0.9% as Native American, and 2.9% as other minority groups. The highest in-hospital mortality among ITP patients was observed in Asian or Pacific Islander individuals (8.83%), followed by African American (8.32%) and those categorized as Other (8.25%). Mortality rates were slightly lower in Native American (7.54%) and White (7.22%) patients, while Hispanic patients had the lowest rate (6.80%), with a p-value <0.001. Conclusion This study reveals significant racial and socio-economic disparities in hospitalization outcomes among patients with ITP. Minority populations, particularly Asian or Pacific Islander, African American, and Native American patients, experienced higher mortality rates. These findings highlight the urgent need for targeted interventions, inclusive clinical research, and policy reforms to address social determinants of health and ensure equitable care and outcomes for all individuals affected by ITP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.